PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.85%
Negative revenue growth while 3141.T stands at 4.86%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-2.33%
Negative gross profit growth while 3141.T is at 11.59%. Joel Greenblatt would examine cost competitiveness or demand decline.
-21.34%
Negative EBIT growth while 3141.T is at 104.79%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-23.85%
Negative operating income growth while 3141.T is at 135.12%. Joel Greenblatt would press for urgent turnaround measures.
-21.96%
Negative net income growth while 3141.T stands at 116.68%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-22.00%
Negative EPS growth while 3141.T is at 119.30%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-22.00%
Negative diluted EPS growth while 3141.T is at 118.66%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.06%
Slight or no buybacks while 3141.T is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.06%
Slight or no buyback while 3141.T is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
5.15%
OCF growth above 1.5x 3141.T's 1.63%. David Dodd would confirm a clear edge in underlying cash generation.
5.15%
FCF growth above 1.5x 3141.T's 1.63%. David Dodd would verify if the firm’s strategic investments yield superior returns.
170.42%
10Y revenue/share CAGR 1.25-1.5x 3141.T's 151.10%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
62.00%
5Y revenue/share CAGR similar to 3141.T's 59.98%. Walter Schloss might see both companies benefiting from the same mid-term trends.
34.07%
3Y revenue/share CAGR 1.25-1.5x 3141.T's 29.78%. Bruce Berkowitz might see better product or regional expansions than the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
99.06%
Below 50% of 3141.T's 349.90%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
23.20%
Below 50% of 3141.T's 95.83%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-9.07%
Negative 3Y CAGR while 3141.T is 5.19%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
341.28%
10Y equity/share CAGR 1.25-1.5x 3141.T's 242.10%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
88.66%
5Y equity/share CAGR 1.25-1.5x 3141.T's 68.46%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
40.10%
3Y equity/share CAGR 1.25-1.5x 3141.T's 32.22%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
140.00%
Below 50% of 3141.T's 353.33%. Michael Burry might see weaker long-term distribution growth, raising questions about the firm's capital allocation.
166.67%
5Y dividend/share CAGR above 1.5x 3141.T's 61.90%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
9.09%
Below 50% of 3141.T's 25.93%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
5.48%
AR growth is negative/stable vs. 3141.T's 13.55%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
6.87%
We show growth while 3141.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
0.24%
Asset growth well under 50% of 3141.T's 1.36%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
2.53%
Under 50% of 3141.T's 5.79%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-5.67%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
2.76%
SG&A growth well above 3141.T's 0.26%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.